Manufacturer copay assistance · Columvi (J9321) · Genentech
$0/dose · Maximum benefit Up to $25,000 per calendar year · Covers Columvi drug cost only — does not cover administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Columvi — the program's cap applies against the patient share CareCost calculates.
Yes — Genentech Oncology Co-Pay Assistance Program from Genentech. Eligible patients may pay as little as $0 per treatment. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients may pay as little as $0 per treatment Maximum benefit: Up to $25,000 per calendar year. Covers Columvi drug cost only — does not cover administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.